Bitter Melon (Momordica charantia) Extract Suppresses Adrenocortical Cancer Cell Proliferation Through Modulation of the Apoptotic Pathway, Steroidogenesis, and Insulin-Like Growth Factor Type 1 Receptor/RAC-α Serine/Threonine-Protein Kinase Signaling

Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf

(2011) Pornsiri Pitchakarn et al.   CANCER LETTERS

mTOR inhibition, a potential novel approach for bronchial carcinoids

(2011) Mei Dong et al.   ENDOCRINE-RELATED CANCER

Synergistic Activation of the Mc2r Promoter by FOXL2 and NR5A1 in Mice1

(2010) Wei-Hsiung Yang et al.   BIOLOGY OF REPRODUCTION

Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice

(2010) Sandra D. Klomann et al.   BRITISH JOURNAL OF NUTRITION

Transcriptome Analysis Reveals that p53 and  -Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers

(2010) B. Ragazzon et al.   CANCER RESEARCH

Bitter Melon (Momordica charantia) Extract Inhibits Breast Cancer Cell Proliferation by Modulating Cell Cycle Regulatory Genes and Promotes Apoptosis

(2010) R. B. Ray et al.   CANCER RESEARCH

Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway

(2010) Lynn S. Adams et al.   CANCER RESEARCH

Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo

(2010) Pornsiri Pitchakarn et al.   CANCER SCIENCE

Momordica charantia Maintains Normal Glucose Levels and Lipid Profiles and Prevents Oxidative Stress in Diabetic Rats Subjected to Chronic Sucrose Load

(2010) Padmaja Chaturvedi et al.   JOURNAL OF MEDICINAL FOOD

Dietary Bitter Melon Seed Increases Peroxisome Proliferator-Activated Receptor-γ Gene Expression in Adipose Tissue, Down-Regulates the Nuclear Factor-κB Expression, and Alleviates the Symptoms Associated with Metabolic Syndrome

(2010) Vidya Gadang et al.   JOURNAL OF MEDICINAL FOOD

Transcatheter Arterial Chemoembolization for Liver Metastases in Patients with Adrenocortical Carcinoma

(2010) Julien Cazejust et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

(2010) H Zhang et al.   ONCOGENE

Incidental and Metastatic Adrenal Masses

(2010) Massimo Mannelli et al.   SEMINARS IN ONCOLOGY

Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review

(2009) Lawrence Leung et al.   BRITISH JOURNAL OF NUTRITION

Genetic p53 Deficiency Partially Rescues the Adrenocortical Dysplasia Phenotype at the Expense of Increased Tumorigenesis

(2009) Tobias Else et al.   CANCER CELL

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

(2009) Paul Haluska et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Eleostearic Acid Inhibits Breast Cancer Proliferation by Means of an Oxidation-Dependent Mechanism

(2009) M. E. Grossmann et al.   Cancer Prevention Research

The Insulin-like Growth Factor-1 Receptor-Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma

(2009) R. T. Kurmasheva et al.   CANCER RESEARCH

Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy

(2009) M. Puri et al.   CURRENT MOLECULAR MEDICINE

In Search of Adrenocortical Stem and Progenitor Cells

(2009) Alex C. Kim et al.   ENDOCRINE REVIEWS

Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas

(2009) P S H Soon et al.   ENDOCRINE-RELATED CANCER

Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model

(2009) Michaela Luconi et al.   ENDOCRINE-RELATED CANCER

Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells

(2009) Su Dao Xiong et al.   INTERNATIONAL JOURNAL OF CANCER

Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats

(2009) Chun-Ching Shih et al.   JOURNAL OF ETHNOPHARMACOLOGY

Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs

(2009) V Ramakrishnan et al.   ONCOGENE

Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus

(2008) Jack H. Wong et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions

(2008) Pratibha V. Nerurkar et al.   BRITISH JOURNAL OF NUTRITION

Expression of Insulin-Like Growth Factor-II and Its Receptor in Pediatric and Adult Adrenocortical Tumors

(2008) Madson Q. Almeida et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma

(2008) Ferdous M. Barlaskar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mechanisms of adrenal gland growth: signal integration by extracellular signal regulated kinases1/2

(2008) Andreas Hoeflich et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY